HomeSUVENPHAR • NSE
add
Suven Pharmaceuticals Ltd
Previous close
₹668.40
Day range
₹655.10 - ₹670.35
Year range
₹469.45 - ₹768.00
Market cap
167.25B INR
Avg Volume
138.35K
P/E ratio
45.08
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.20B | -37.86% |
Operating expense | 622.85M | -0.05% |
Net income | 467.54M | -56.60% |
Net profit margin | 21.27 | -30.15% |
Earnings per share | — | — |
EBITDA | 640.08M | -55.53% |
Effective tax rate | 28.59% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.54B | 82.76% |
Total assets | 20.58B | — |
Total liabilities | 765.00M | — |
Total equity | 19.81B | — |
Shares outstanding | 254.10M | — |
Price to book | 8.57 | — |
Return on assets | 6.27% | — |
Return on capital | 6.55% | — |
Cash Flow
Net change in cash
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 467.54M | -56.60% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2018
Website
Employees
1,165